(Q40086117)

17 September 2017

1 reference

title

Secondary prevention after myocardial infarction: a review of long-term trials (English)

1 reference

17 September 2017

Secondary prevention after myocardial infarction: A review of long-term trials (English)

1 reference

https://api.crossref.org/works/10.1016/0033-0620(82)90010-X

Cardiology and cardiovascular medicine

8 August 2023

main subject

myocardial infarction

1 reference

based on heuristic

inferred from title

1 reference

https://api.crossref.org/works/10.1016/0033-0620(82)90010-X

8 August 2023

author name string

G. S. May

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6119737

8 August 2023

K. A. Eberlein

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6119737

8 August 2023

C. D. Furberg

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6119737

8 August 2023

E. R. Passamani

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6119737

8 August 2023

D. L. DeMets

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6119737

8 August 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6119737

8 August 2023

publication date

1 January 1982

1 reference

full work available at URL

17 September 2017

https://api.elsevier.com/content/article/PII:003306208290010X?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0033-0620(82)90010-X

https://api.elsevier.com/content/article/PII:003306208290010X?httpAccept=text/plain

8 August 2023

1 reference

https://api.crossref.org/works/10.1016/0033-0620(82)90010-X

Progress in Cardiovascular Diseases

8 August 2023

published in

1 reference

17 September 2017

volume

24

1 reference

17 September 2017

issue

4

1 reference

17 September 2017

page(s)

331-352

1 reference

Prognosis of men after first myocardial infarction: mortality and first recurrence in relation to selected parameters

17 September 2017

cites work

4

1 reference

https://api.crossref.org/works/10.1016/0033-0620(82)90010-X

IMMEDIATE MORTALITY AND FIVE-YEAR SURVIVAL OF EMPLOYED MEN WITH A FIRST MYOCARDIAL INFARCTION

8 August 2023

6

1 reference

https://api.crossref.org/works/10.1016/0033-0620(82)90010-X

Treatment of myocardial infarction in a coronary care unit. A two year experience with 250 patients

8 August 2023

7

1 reference

https://api.crossref.org/works/10.1016/0033-0620(82)90010-X

Changing patterns and mortality of acute myocardial infarction in a coronary care unit

8 August 2023

8

1 reference

https://api.crossref.org/works/10.1016/0033-0620(82)90010-X

The randomized clinical trial: bias in analysis

8 August 2023

9

1 reference

https://api.crossref.org/works/10.1016/0033-0620(82)90010-X

Influence of adherence to treatment and response of cholesterol on mortality in the coronary drug project

8 August 2023

10

1 reference

https://api.crossref.org/works/10.1016/0033-0620(82)90010-X

Effect on survival after myocardial infarction of long-term treatment with phenytoin

8 August 2023

13

1 reference

https://api.crossref.org/works/10.1016/0033-0620(82)90010-X

Prophylaxis of ventricular tachyarrhythmias with intravenous and oral tocainide in patients with and recovering from acute myocardial infarction

8 August 2023

14

1 reference

https://api.crossref.org/works/10.1016/0033-0620(82)90010-X

A prospective randomized trial of tocainide in patients following myocardial infarction

8 August 2023

15

1 reference

https://api.crossref.org/works/10.1016/0033-0620(82)90010-X

Oral mexiletine in high-risk patients after myocardial infarction

8 August 2023

16

1 reference

https://api.crossref.org/works/10.1016/0033-0620(82)90010-X

Relationship of blood pressure, serum cholesterol, smoking habit, relative weight and ECG abnormalities to incidence of major coronary events: final report of the pooling project. The pooling project research group

8 August 2023

18

1 reference

https://api.crossref.org/works/10.1016/0033-0620(82)90010-X

Natural history of myocardial infarction in the coronary drug project: long-term prognostic importance of serum lipid levels. Coronary Drug Project Research Group

8 August 2023

19

1 reference

https://api.crossref.org/works/10.1016/0033-0620(82)90010-X

Influence of reduction of serum lipids on prognosis of coronary heart-disease. A five-year study using oestrogen

8 August 2023

20

1 reference

https://api.crossref.org/works/10.1016/0033-0620(82)90010-X

Effectiveness of estrogens for therapy of myocardial infarction in middle-age men

8 August 2023

21

1 reference

https://api.crossref.org/works/10.1016/0033-0620(82)90010-X

The Oslo diet-heart study. Eleven-year report

8 August 2023

23

1 reference

https://api.crossref.org/works/10.1016/0033-0620(82)90010-X

Long-term changes of serum cholesterol with cholesterol-altering drugs in patients with coronary heart disease. Veterans Administration Drug-Lipid Cooperative Study

8 August 2023

29

1 reference

https://api.crossref.org/works/10.1016/0033-0620(82)90010-X

Reduction of myocardial reinfarction by the combined treatment with clofibrate and nicotinic acid

8 August 2023

32

1 reference

https://api.crossref.org/works/10.1016/0033-0620(82)90010-X

Effect of combined clofibrate--nicotinic acid treatment in ischemic heart disease

8 August 2023

33

1 reference

https://api.crossref.org/works/10.1016/0033-0620(82)90010-X

Anticoagulants in coronary heart disease--retrospect and prospect

8 August 2023

37

1 reference

https://api.crossref.org/works/10.1016/0033-0620(82)90010-X

AN ASSESSMENT OF LONG-TERM ANTICOAGULANT ADMINISTRATION AFTER CARDIAC INFARCTION. SECOND REPORT OF THE WORKING PARTY ON ANTICOAGULANT THERAPY IN CORONARY THROMBOSIS TO THE MEDICAL RESEARCH COUNCIL

8 August 2023

39

1 reference

https://api.crossref.org/works/10.1016/0033-0620(82)90010-X

Anticoagulants in acute myocardial infarction. The failure of anticoagulants to alter mortality in a randomized series

8 August 2023

40

1 reference

https://api.crossref.org/works/10.1016/0033-0620(82)90010-X

Long-term anticoagulant prophylaxis after myocardial infarction

8 August 2023

41

1 reference

https://api.crossref.org/works/10.1016/0033-0620(82)90010-X

Secondary prevention of myocardial infarction. Comparison of acetylsalicylic acid, phenprocoumon and placebo. A multicenter two-year prospective study

8 August 2023

43

1 reference

https://api.crossref.org/works/10.1016/0033-0620(82)90010-X

A Randomized Controlled Trial of Acetyl Salicyclic Acid in the Secondary Prevention of Mortality from Myocardial Infarction

8 August 2023

46

1 reference

https://api.crossref.org/works/10.1016/0033-0620(82)90010-X

Aspirin and secondary mortality after myocardial infarction

8 August 2023

48

1 reference

https://api.crossref.org/works/10.1016/0033-0620(82)90010-X

Persantine and aspirin in coronary heart disease. The Persantine-Aspirin Reinfarction Study Research Group

8 August 2023

50

1 reference

https://api.crossref.org/works/10.1016/0033-0620(82)90010-X

Sulfinpyrazone in the prevention of cardiac death after myocardial infarction. The Anturane Reinfarction Trial

8 August 2023

51

1 reference

https://api.crossref.org/works/10.1016/0033-0620(82)90010-X

Sulfinpyrazone in the prevention of sudden death after myocardial infarction

8 August 2023

52

1 reference

https://api.crossref.org/works/10.1016/0033-0620(82)90010-X

A randomized controlled trial of aspirin in the prevention of early mortality in myocardial infarction

8 August 2023

53

1 reference

https://api.crossref.org/works/10.1016/0033-0620(82)90010-X

The FDA's critique of the anturane reinfarction trial

8 August 2023

54

1 reference

https://api.crossref.org/works/10.1016/0033-0620(82)90010-X

Aspirin: A paradoxical effect on bleeding-time

8 August 2023

55

1 reference

https://api.crossref.org/works/10.1016/0033-0620(82)90010-X

Reduction of sudden deaths after myocardial infarction by treatment with alprenolol. Preliminary results

8 August 2023

57

1 reference

https://api.crossref.org/works/10.1016/0033-0620(82)90010-X

Letter: Reduction of sudden Deaths after myocardial infarction

8 August 2023

59

1 reference

https://api.crossref.org/works/10.1016/0033-0620(82)90010-X

Long-term treatment with ?-blockers after myocardial infarction

8 August 2023

60

1 reference

https://api.crossref.org/works/10.1016/0033-0620(82)90010-X

Practolol in acute myocardial infarction

8 August 2023

61

1 reference

https://api.crossref.org/works/10.1016/0033-0620(82)90010-X

Improvement in prognosis of myocardial infarction by long-term beta-adrenoreceptor blockade using practolol. A multicentre international study

8 August 2023

62

1 reference

https://api.crossref.org/works/10.1016/0033-0620(82)90010-X

Reduction in mortality after myocardial infarction with long-term beta-adrenoceptor blockade. Multicentre international study: supplementary report

8 August 2023

63

1 reference

https://api.crossref.org/works/10.1016/0033-0620(82)90010-X

Effect of alprenolol on mortality among patients with definite or suspected acute myocardial infarction. Preliminary results

8 August 2023

64

1 reference

https://api.crossref.org/works/10.1016/0033-0620(82)90010-X

Multicentre post-infarction trial of propranolol in 49 hospitals in the United Kingdom, Italy, and Yugoslavia

8 August 2023

65

1 reference

https://api.crossref.org/works/10.1016/0033-0620(82)90010-X

Randomised trial comparing propranolol with atenolol in immediate treatment of suspected myocardial infarction

8 August 2023

66

1 reference

https://api.crossref.org/works/10.1016/0033-0620(82)90010-X

Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction

8 August 2023

67

1 reference

https://api.crossref.org/works/10.1016/0033-0620(82)90010-X

Exercise tolerance and physical training of non-selected patients after myocardial infarction

8 August 2023

68

1 reference

https://api.crossref.org/works/10.1016/0033-0620(82)90010-X

A controlled trial of physical training after myocardial infarction. Effects on risk factors, nonfatal reinfarction, and death

8 August 2023

69

1 reference

https://api.crossref.org/works/10.1016/0033-0620(82)90010-X

Physical fitness and feasibility of physical rehabilitation after myocardial infarction in men of working age

8 August 2023

70

1 reference

https://api.crossref.org/works/10.1016/0033-0620(82)90010-X

Reduction in sudden deaths by a multifactorial intervention programme after acute myocardial infarction

8 August 2023

72

1 reference

https://api.crossref.org/works/10.1016/0033-0620(82)90010-X

A controlled prospective study of the effect of endurance training on the recurrence rate of myocardial infarction. A description of the experimental design

8 August 2023

75

1 reference

https://api.crossref.org/works/10.1016/0033-0620(82)90010-X

Anticoagulants and myocardial infarction. The problems of pooling, drowning, and floating

8 August 2023

77

1 reference

https://api.crossref.org/works/10.1016/0033-0620(82)90010-X

Evidence favoring the use of anticoagulants in the hospital phase of acute myocardial infarction

8 August 2023

78

1 reference

https://api.crossref.org/works/10.1016/0033-0620(82)90010-X

Natural history of coronary artery disease

8 August 2023

80

1 reference

https://api.crossref.org/works/10.1016/0033-0620(82)90010-X

Hazards in the evaluation of secondary prevention trials

8 August 2023

81

1 reference

https://api.crossref.org/works/10.1016/0033-0620(82)90010-X

8 August 2023

Identifiers

1 reference

17 September 2017

1 reference